AI/Nov 16 edition/Reporting & analysis
BusinessInfrastructure

BusinessMarkets, money & strategy

Wall Street's 10 biggest IPOs of 2026 trade 20.5% below offer as Anthropic prepares to list

The ten largest US listings of 2026 are trading an average 20.5% below their offer prices, the first such loss in five years. AI chip names are among the laggards, just as Anthropic prepares a listing valued at up to about $1.4tn.

From the Financial Times · AI article of November 16, 2026 and cited sources: The year's 10 largest US IPOs are down an average of 20.5% from their offer prices. [2] [3] [11]

SOURCES[2] Techmeme / FT summary techmeme.com[3] Dealroom: Biggest IPOs this year lose investors money dealroom.co[11] AI Weekly aiweekly.co

AI-assisted, not human-edited. Methodology Corrections Who owns this site

KEY FACTS
What happened
The year's 10 largest US IPOs are down an average of 20.5% from their offer prices. [2] [3] [11]
Original source
Financial Times · AI article, independent perspective
Brief by
AT Pulse research desk AI-assisted; publisher and contact on the desk page
When
November 16, 2026 article published
Evidence
16 sources across 15 sites

Reach: not measured yet

THE CORE IDEAS3 TAKEAWAYS
01

The year's 10 largest US IPOs are down an average of 20.5% from their offer prices. This group finished each of the previous four years in profit, including 2022, when the S&P 500 fell 19.4%. Deal value is still at its highest this decade, so the weakness is in aftermarket returns, not in the number of deals. [2] [3] [11]

02

AI hardware listings are among the losers. One analysis put SK Hynix's US receipts 11.6% below their $149 offer on November 13. Cerebras priced at $185 and closed its first day up about 68%, but it has still lost ground. The slump is linked partly to an October chip sell-off. SpaceX, the largest listing, is roughly flat against its $135 offer. [3] [4] [5] [8] [14]

03

Anthropic plans to sell 825M shares at $70–78 each, with pricing set for November 18 and trading for November 19. That implies a valuation of about $1.4tn. Fund managers reportedly see the debut as a test for their year's performance and for appetite for new AI issues. [3] [9] [10]

WHY IT MATTERS

the year's largest listings, several of them AI-linked, trade below their offer prices after a chip sell-off. Implication: investors may push for lower AI IPO valuations, and Anthropic's debut will show whether demand for AI listings holds up.

Executive brief

For the first time in five years, the 10 largest US listings of the year are worth less than their offer prices. According to the Financial Times, via Techmeme, they are down an average of 20.5%. In each of the previous four years this group ended the year in profit, even in 2022, when the S&P 500 fell 19.4% (Dealroom summary of FT). The losers include AI hardware companies such as SK Hynix and Cerebras. SpaceX, the largest listing, is roughly flat. Anthropic plans to list this week at a valuation of up to about $1.4tn, so it debuts into a weak market for new issues.

What changed and event timeline

  1. Cerebras prices above range

    Cerebras sold 30M shares at $185 and began trading on Nasdaq as CBRS. Shares closed the first day up about 68% (;).

  2. SpaceX sets an IPO record

    SpaceX priced at $135 a share to raise $75bn, at a valuation of about $1.75tn. It opened at $150 on Nasdaq (;).

  3. SK Hynix lists ADRs in the US

    SK Hynix priced American depositary receipts at $149 and raised $26.5bn. Al Jazeera called it the largest US listing ever by a foreign company, ahead of Alibaba's 2014 deal ().

  4. Chip stocks sell off

    The FT links the IPO slump partly to an October chip sell-off. Intel has fallen 45% since September 30 ().

  5. Anthropic files to list

    The filing offers 825M shares at $70–78 under the ticker ANT. Pricing is set for November 18 and trading for November 19 (;).

  6. FT reports the IPO class is under water

    The 10 biggest 2026 listings are down 20.5% on average from offer (;).

Capabilities and access

The reviewed sources do not name all ten companies in the FT's group.

Read the full section
  • SpaceX (SPCX): priced at $135. It has traded around that price for much of the past month (Dealroom/FT).
  • SK Hynix: $149 per ADR, where each ADR is one-tenth of a Korean common share (NST).
  • Cerebras (CBRS): priced at $185.
  • Anthropic (ANT): up to 20% of the offering is aimed at retail investors (CNBC).
  • Moonshot: plans a Hong Kong listing (AI Weekly).

The reviewed sources do not name all ten companies in the FT's group.

Technical analysis for researchers and developers

  • How the figure is measured: returns are taken against offer prices, not first-day closes.
  • Averaging: the 20.5% looks like a simple average across the ten companies, not weighted by deal size.
  • Paper-loss estimate: FourWeekMBA estimates a net paper loss of about $3.7bn on base-deal shares for the seven listings below offer, as of the November 13 close (FourWeekMBA).
Read the full section
  • How the figure is measured: returns are taken against offer prices, not first-day closes. Investors who bought on day one have done worse than the 20.5% suggests, because Cerebras alone closed its first day 68% above offer.
  • Averaging: the 20.5% looks like a simple average across the ten companies, not weighted by deal size. If so, the roughly flat SpaceX deal counts no more than smaller deals.
  • Paper-loss estimate: FourWeekMBA estimates a net paper loss of about $3.7bn on base-deal shares for the seven listings below offer, as of the November 13 close (FourWeekMBA).
  • Reproducibility: the result depends on the cutoff date. Prices from November 13 and November 16 can give different averages.

Claims and evidence

  • Average decline of 20.5% and four prior years of gains: these come from the FT's own analysis and are reported through Techmeme and Dealroom.
  • Seven of ten below offer; SpaceX +3.0%; SK Hynix −11.6% on November 13: these come from one secondary analysis (FourWeekMBA).
  • Size of SpaceX's deal: most outlets report $75bn (Renaissance Capital). The gap is unexplained.
Read the full section
  • Average decline of 20.5% and four prior years of gains: these come from the FT's own analysis and are reported through Techmeme and Dealroom. The reviewed sources do not include independent calculations of the same basket.
  • Seven of ten below offer; SpaceX +3.0%; SK Hynix −11.6% on November 13: these come from one secondary analysis (FourWeekMBA).
  • Size of SpaceX's deal: most outlets report $75bn (Renaissance Capital). CNBC cites $86bn (CNBC), which may include extra shares sold after the IPO. The gap is unexplained.
  • Cerebras's current price: none of the reviewed sources reports it.

Context and prior work

US IPO deal value in 2026 is the highest this decade (AI Weekly). Several deals set records: Anthropic's valuation range sits above its $965bn private round in May. It is below the Wall Street estimates of up to $2tn made in October (Yahoo Finance).

Read the full section

US IPO deal value in 2026 is the highest this decade (AI Weekly). Several deals set records:

  • SpaceX is the largest US IPO on record.
  • SK Hynix passed Alibaba's $25bn deal from 2014 as the largest US listing by a foreign company (Al Jazeera).
  • Cerebras's IPO price valued it at more than double its $23bn private valuation from February (Yahoo Finance).

Anthropic's valuation range sits above its $965bn private round in May. It is below the Wall Street estimates of up to $2tn made in October (Yahoo Finance).

Limitations, safety and contested findings

  • Anthropic is reported at $1.405tn at the current price range (CNBC) and up to $1.75tn on a fully diluted basis (Crypto Briefing).
  • Anthropic's risk factors: reporting highlights $895.4bn of purchase commitments in the revised S-1, scrutiny from the FTC, and disputes with the Department of Defense (CNBC).
  • Cause of the slump: reporting links it to the October chip sell-off, but no source separates that effect from problems specific to individual issuers.
Read the full section
  • Valuation figures differ by method. Anthropic is reported at $1.405tn at the current price range (CNBC) and up to $1.75tn on a fully diluted basis (Crypto Briefing).
  • Anthropic's risk factors: reporting highlights $895.4bn of purchase commitments in the revised S-1, scrutiny from the FTC, and disputes with the Department of Defense (CNBC).
  • Cause of the slump: reporting links it to the October chip sell-off, but no source separates that effect from problems specific to individual issuers.

Business and practitioner implications

  • For issuers: pricing above range, as Cerebras did, does not protect returns months later.
  • For investors: fund managers reportedly see Anthropic as a test that could make or break their year.
  • For AI buyers: newly listed suppliers now face pressure from public markets.
Read the full section
  • For issuers: pricing above range, as Cerebras did, does not protect returns months later. Expect investors to demand lower IPO valuations in AI deals, especially for hardware companies tied to chip cycles.
  • For investors: fund managers reportedly see Anthropic as a test that could make or break their year. One manager said a weak debut "could screw up my entire year" (Dealroom/FT).
  • For AI buyers: newly listed suppliers now face pressure from public markets. Watch how financing and pricing behave at suppliers whose shares trade below offer.
FOLLOW THE EVIDENCE

The source trail.

Sources (16)
A LITTLE LESS NOISE. A LOT MORE CONTEXT.

Stay curious.
Follow the evidence.

Independent perspectives, the original sources, and room for the questions that don't have easy answers.

How we build the brief
Connect with us

Find us where you already read.